ZOETIS Duvaxyn Ehv 1,4 1ml X 10

Product at a Glance
Inactivated herpesvirus vaccine for use in horses.

Recommendations for Use
For the vaccination of healthy horses and ponies for reduction in the clinical signs of the respiratory diseases caused by EHV-1 and EHV-4.

For use as an aid in the control of EHV-1 abortion when used in conjunction with appropriate management practices. Pregnant mares vaccinated with this product may still abort.

The vaccine is recommended for use in healthy horses and ponies from five months of age.

Clinical Use

Vaccination against respiratory disease
Primary course: A single dose of Duvaxyn EHV1,4 should be administered from five months of age followed by a second injection of Duvaxyn EHV1,4 after an interval of 4-6 weeks. In the event of increased infection risk, for example when a foal has consumed insufficient colostrum or there is risk of early exposure to field infections with EHV-1 or EHV-4, an earlier vaccination may be given. In these circumstances the foal should receive a single dose of Duvaxyn EHV1,4 from three months of age followed by the above mentioned full primary vaccination course.

Boosting immunity: Following completion of the primary course, a single dose of Duvaxyn EHV1,4 should be administered every six months.

Vaccination to aid in the control of abortion
For use as an aid in the control of EHV-1 abortion when used in conjunction with appropriate management practices. (Pregnant mares that have been previously primed should be vaccinated during the 5th, 7th and 9th months of pregnancy with a single dose on each occasion). Infected, pregnant mares vaccinated with this product may still abort.

Presentation
10 x 1 mL dose vials.